Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 365

1.

Geriatric assessment of patients treated for cutaneous head and neck malignancies in a tertiary referral center: Predictors of postoperative complications.

de Vries J, Heirman AN, Bras L, Plaat BEC, Rácz E, van Kester MS, Festen S, de Bock GH, van der Laan BFAM, Halmos GB.

Eur J Surg Oncol. 2019 Aug 10. pii: S0748-7983(19)30620-1. doi: 10.1016/j.ejso.2019.08.008. [Epub ahead of print]

PMID:
31427138
2.

GlycA, a novel pro-inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta-analysis.

Gruppen EG, Kunutsor SK, Kieneker LM, van der Vegt B, Connelly MA, de Bock GH, Gansevoort RT, Bakker SJL, Dullaart RPF.

J Intern Med. 2019 Jul 1. doi: 10.1111/joim.12953. [Epub ahead of print]

PMID:
31260573
3.

CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.

Zwart AT, van der Hoorn A, van Ooijen PMA, Steenbakkers RJHM, de Bock GH, Halmos GB.

J Cachexia Sarcopenia Muscle. 2019 May 27. doi: 10.1002/jcsm.12443. [Epub ahead of print]

4.

Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.

Du Y, Zhao Y, Sidorenkov G, de Bock GH, Cui X, Huang Y, Dorrius MD, Rook M, Groen HJM, Heuvelmans MA, Vliegenthart R, Chen K, Xie X, Liu S, Oudkerk M, Ye Z.

Cancer Biol Med. 2019 Feb;16(1):181-188. doi: 10.20892/j.issn.2095-3941.2018.0237.

5.

Margin status revisited in vulvar squamous cell carcinoma.

Te Grootenhuis NC, Pouwer AW, de Bock GH, Hollema H, Bulten J, van der Zee AGJ, de Hullu JA, Oonk MHM.

Gynecol Oncol. 2019 Aug;154(2):266-275. doi: 10.1016/j.ygyno.2019.05.010. Epub 2019 May 18.

PMID:
31109660
6.

The systemic impact of a surgical procedure in older oncological patients.

Plas M, de Haan JJ, van der Wal-Huisman H, Rutgers A, Absalom AR, de Bock GH, van Leeuwen BL.

Eur J Surg Oncol. 2019 Aug;45(8):1403-1409. doi: 10.1016/j.ejso.2019.04.024. Epub 2019 May 3.

PMID:
31104780
7.

How to incorporate geriatric assessment in clinical decision-making for older patients with cancer. An implementation study.

Festen S, Kok M, Hopstaken JS, van der Wal-Huisman H, van der Leest A, Reyners AKL, de Bock GH, de Graeff P, van Leeuwen BL.

J Geriatr Oncol. 2019 Apr 25. pii: S1879-4068(18)30418-1. doi: 10.1016/j.jgo.2019.04.006. [Epub ahead of print]

PMID:
31031193
8.

Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.

Xia C, Rook M, Pelgrim GJ, Sidorenkov G, Wisselink HJ, van Bolhuis JN, van Ooijen PMA, Guo J, Oudkerk M, Groen H, van den Berge M, van der Harst P, Dijkstra H, Vonder M, Heuvelmans MA, Dorrius MD, De Deyn PP, de Bock GH, Dotinga A, Vliegenthart R.

Eur J Epidemiol. 2019 Apr 23. doi: 10.1007/s10654-019-00519-0. [Epub ahead of print]

PMID:
31016436
9.

Not type of induction therapy but consolidation with allogeneic hematopoietic cell transplantation determines outcome in older AML patients: A single center experience of 355 consecutive patients.

Hilberink J, Hazenberg C, van den Berg E, Mulder A, Schuringa JJ, van der Helm L, de Groot M, Choi G, de Bock GH, Vellenga E, Ammatuna E, Huls G.

Leuk Res. 2019 May;80:33-39. doi: 10.1016/j.leukres.2019.03.004. Epub 2019 Mar 18.

10.

Determinants of health-related quality of life in elderly ovarian cancer patients: The role of frailty and dependence.

de Arruda FN, Oonk MHM, Mourits MJE, de Graeff P, Jalving M, de Bock GH.

Gynecol Oncol. 2019 Jun;153(3):610-615. doi: 10.1016/j.ygyno.2019.03.249. Epub 2019 Mar 29.

PMID:
30935716
11.

Acceptance of contralateral reduction mammoplasty after oncoplastic breast conserving surgery: A semi-structured qualitative interview study.

Smeele HP, Van der Does de Willebois EML, Eltahir Y, De Bock GH, Van Aalst VC, Jansen L.

Breast. 2019 Jun;45:97-103. doi: 10.1016/j.breast.2019.03.008. Epub 2019 Mar 25.

PMID:
30928763
12.

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis.

Phi XA, Greuter MJW, Obdeijn IM, Oosterwijk JC, Feenstra TL, Houssami N, de Bock GH.

Breast. 2019 Jun;45:82-88. doi: 10.1016/j.breast.2019.03.004. Epub 2019 Mar 12.

PMID:
30904701
13.

Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil.

Guindalini RSC, Cormedi MCV, Maistro S, Pasini FS, Branas PCAA, Dos Santos L, de Lima Pereira GF, de Bock GH, Saccaro DM, Katayama MLH, Faraj SF, Safatle-Ribeiro A, Ribeiro Junior U, Diz MDPE, de Gouvêa ACRC, Chammas R, Folgueira MAAK.

Gastric Cancer. 2019 Sep;22(5):920-931. doi: 10.1007/s10120-019-00945-9. Epub 2019 Mar 20.

PMID:
30895400
14.

Web-based personalised information and support for patients with a neuroendocrine tumour: randomised controlled trial.

de Hosson LD, Bouma G, Stelwagen J, van Essen H, de Bock GH, de Groot DJA, de Vries EGE, Walenkamp AME.

Orphanet J Rare Dis. 2019 Feb 28;14(1):60. doi: 10.1186/s13023-019-1035-3.

15.

Cardiac Function After Radiation Therapy for Breast Cancer.

van den Bogaard VAB, van Luijk P, Hummel YM, van der Meer P, Schuit E, Boerman LM, Maass SWMC, Nauta JF, Steggink LC, Gietema JA, de Bock GH, Berendsen AJ, Smit WGJM, Sijtsema NM, Kierkels RGJ, Langendijk JA, Crijns APG, Maduro JH.

Int J Radiat Oncol Biol Phys. 2019 Jun 1;104(2):392-400. doi: 10.1016/j.ijrobp.2019.02.003. Epub 2019 Feb 11.

PMID:
30763659
16.

The Effect of Smoking and Body Mass Index on The Complication Rate of Alloplastic Breast Reconstruction.

Sadok N, Krabbe-Timmerman IS, de Bock GH, Werker PMN, Jansen L.

Scand J Surg. 2019 Feb 3:1457496919826711. doi: 10.1177/1457496919826711. [Epub ahead of print]

PMID:
30712467
17.

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study.

Leimkühler M, Hemmer PHJ, Reyners AKL, de Groot DJA, van Ginkel RJ, Been LB, de Bock GH, van Leeuwen BL.

World J Surg Oncol. 2019 Jan 11;17(1):14. doi: 10.1186/s12957-018-1554-8.

18.

Response-guided chemotherapy for pediatric acute myeloid leukemia without hematopoietic stem cell transplantation in first complete remission: Results from protocol DB AML-01.

De Moerloose B, Reedijk A, de Bock GH, Lammens T, de Haas V, Denys B, Dedeken L, van den Heuvel-Eibrink MM, Te Loo M, Uyttebroeck A, Van Damme A, Van der Werff-Ten Bosch J, Zsiros J, Kaspers G, de Bont E.

Pediatr Blood Cancer. 2019 May;66(5):e27605. doi: 10.1002/pbc.27605. Epub 2019 Jan 8.

PMID:
30623572
19.

Persisting new nodules in incidence rounds of the NELSON CT lung cancer screening study.

Walter JE, Heuvelmans MA, Ten Haaf K, Vliegenthart R, van der Aalst CM, Yousaf-Khan U, van Ooijen PMA, Nackaerts K, Groen HJM, De Bock GH, de Koning HJ, Oudkerk M.

Thorax. 2019 Mar;74(3):247-253. doi: 10.1136/thoraxjnl-2018-212152. Epub 2018 Dec 27.

PMID:
30591535
20.

Age should not be a limiting factor in laparoscopic surgery: a prospective multicenter cohort study on quality of life after laparoscopic hysterectomy.

Briët JM, Mourits MJ, van Leeuwen BL, van den Heuvel ER, Kenkhuis MJ, Arts HJ, de Bock GH.

Clin Interv Aging. 2018 Dec 13;13:2517-2526. doi: 10.2147/CIA.S172965. eCollection 2018.

21.

What is the added value of digital image analysis of HER2 immunohistochemistry in breast cancer in clinical practice? A study with multiple platforms.

Koopman T, Buikema HJ, Hollema H, de Bock GH, van der Vegt B.

Histopathology. 2019 May;74(6):917-924. doi: 10.1111/his.13812. Epub 2019 Apr 1.

PMID:
30585668
22.

Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.

Heuvelmans MA, Vonder M, Rook M, Groen HJM, De Bock GH, Xie X, Ijzerman MJ, Vliegenthart R, Oudkerk M.

J Thorac Imaging. 2019 May;34(3):160-169. doi: 10.1097/RTI.0000000000000379.

PMID:
30550403
23.

Relationship between the number of new nodules and lung cancer probability in incidence screening rounds of CT lung cancer screening: The NELSON study.

Walter JE, Heuvelmans MA, de Bock GH, Yousaf-Khan U, Groen HJM, van der Aalst CM, Nackaerts K, van Ooijen PMA, de Koning HJ, Vliegenthart R, Oudkerk M.

Lung Cancer. 2018 Nov;125:103-108. doi: 10.1016/j.lungcan.2018.05.007. Epub 2018 May 14.

24.

Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.

Weerink LBM, Gant CM, van Leeuwen BL, de Bock GH, Kouwenhoven EA, Faneyte IF.

Ann Surg Oncol. 2018 Dec;25(13):3874-3882. doi: 10.1245/s10434-018-6766-1. Epub 2018 Sep 22.

25.

Mindfulness-based stress reduction for menopausal symptoms after risk-reducing salpingo-oophorectomy (PURSUE study): a randomised controlled trial.

van Driel C, de Bock GH, Schroevers MJ, Mourits MJ.

BJOG. 2019 Feb;126(3):402-411. doi: 10.1111/1471-0528.15471. Epub 2018 Oct 23.

26.

Quality of Life and Sexual Functioning After Vulvar Reconstruction With the Lotus Petal Flap.

Hellinga J, Te Grootenhuis NC, Werker PMN, de Bock GH, van der Zee AGJ, Oonk MHM, Stenekes MW.

Int J Gynecol Cancer. 2018 Nov;28(9):1728-1736. doi: 10.1097/IGC.0000000000001340.

PMID:
30157166
27.

L1CAM expression in uterine carcinosarcoma is limited to the epithelial component and may be involved in epithelial-mesenchymal transition.

Versluis M, Plat A, de Bruyn M, Matias-Guiu X, Trovic J, Krakstad C, Nijman HW, Bosse T, de Bock GH, Hollema H.

Virchows Arch. 2018 Nov;473(5):591-598. doi: 10.1007/s00428-018-2444-8. Epub 2018 Aug 23.

PMID:
30140948
28.

Optimal unidirectional switch designs.

Zhan Z, de Bock GH, van den Heuvel ER.

Stat Med. 2018 Nov 10;37(25):3573-3588. doi: 10.1002/sim.7853. Epub 2018 Jul 12.

PMID:
30003557
29.

HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in-situ hybridisation.

Koopman T, van der Vegt B, Dijkstra M, Bart J, Duiker E, Wisman GBA, de Bock GH, Hollema H.

Histopathology. 2018 Nov;73(5):852-863. doi: 10.1111/his.13704. Epub 2018 Sep 19.

PMID:
29989198
30.

Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.

Teixeira N, Mourits MJ, Oosterwijk JC, Fakkert IE, Absalom AR, Bakker SJL, van der Meer P, de Bock GH.

Fam Cancer. 2019 Jan;18(1):19-27. doi: 10.1007/s10689-018-0091-5.

31.

Characteristics of Lynch syndrome associated ovarian cancer.

Woolderink JM, De Bock GH, de Hullu JA, Hollema H, Zweemer RP, Slangen BFM, Gaarenstroom KN, van Beurden M, van Doorn HC, Sijmons RH, Vasen HFA, Mourits MJE.

Gynecol Oncol. 2018 Aug;150(2):324-330. doi: 10.1016/j.ygyno.2018.03.060. Epub 2018 Jun 5.

PMID:
29880284
32.

Corrigendum to "A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening" [Maturitas 109 (2018) 81-88].

Koleva-Kolarova RG, Daszczuk AM, de Jonge C, Abu Hantash MK, Zhan ZZ, Postema EJ, Feenstra TL, Pijnappel RM, Greuter MJW, de Bock GH.

Maturitas. 2018 Aug;114:73. doi: 10.1016/j.maturitas.2018.05.005. Epub 2018 May 17. No abstract available.

PMID:
29779854
33.

Molecular imaging with positron emission tomography and computed tomography (PET/CT) for selecting first-line targeted treatment in metastatic breast cancer: a cost-effectiveness study.

Koleva-Kolarova RG, Greuter MJW, Feenstra TL, Vermeulen KM, de Vries EFJ, Parkin D, Buskens E, de Bock GH.

Oncotarget. 2018 Apr 13;9(28):19836-19846. doi: 10.18632/oncotarget.24869. eCollection 2018 Apr 13.

34.

Azathioprine to mycophenolate mofetil transition and risk of squamous cell carcinoma after lung transplantation.

Vos M, Plasmeijer EI, van Bemmel BC, van der Bij W, Klaver NS, Erasmus ME, de Bock GH, Verschuuren EAM, Rácz E.

J Heart Lung Transplant. 2018 Jul;37(7):853-859. doi: 10.1016/j.healun.2018.03.012. Epub 2018 Mar 19.

PMID:
29680587
35.

Severity and duration of menopausal symptoms after risk-reducing salpingo-oophorectomy.

Stuursma A, van Driel CMG, Wessels NJ, de Bock GH, Mourits MJE.

Maturitas. 2018 May;111:69-76. doi: 10.1016/j.maturitas.2018.01.012. Epub 2018 Jan 13.

PMID:
29673834
36.

Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review.

Spronk I, Schellevis FG, Burgers JS, de Bock GH, Korevaar JC.

Breast. 2018 Jun;39:70-79. doi: 10.1016/j.breast.2018.03.011. Epub 2018 Apr 2. Review.

PMID:
29621695
37.

Digital breast tomosynthesis for breast cancer screening and diagnosis in women with dense breasts - a systematic review and meta-analysis.

Phi XA, Tagliafico A, Houssami N, Greuter MJW, de Bock GH.

BMC Cancer. 2018 Apr 3;18(1):380. doi: 10.1186/s12885-018-4263-3. Review.

38.

Is the incidence of advanced-stage breast cancer affected by whether women attend a steady-state screening program?

de Munck L, Fracheboud J, de Bock GH, den Heeten GJ, Siesling S, Broeders MJM.

Int J Cancer. 2018 Aug 15;143(4):842-850. doi: 10.1002/ijc.31388. Epub 2018 Apr 6.

39.

High-pitch versus sequential mode for coronary calcium in individuals with a high heart rate: Potential for dose reduction.

Vonder M, Vliegenthart R, Kaatee MA, van der Aalst CM, van Ooijen PMA, de Bock GH, Gratama JW, Kuijpers D, de Koning HJ, Oudkerk M.

J Cardiovasc Comput Tomogr. 2018 Jul - Aug;12(4):298-304. doi: 10.1016/j.jcct.2018.02.005. Epub 2018 Mar 1.

PMID:
29551663
40.

Semi-automatic tumour volume measurements on MR-Imaging using smartbrush® in oropharyngeal carcinomas; our experience in 5 patients.

Lodder WL, Dorgelo B, Lancaster J, Hanlon R, Wieshmann H, de Bock GH, van der Laan BFAM.

Clin Otolaryngol. 2018 Mar 15. doi: 10.1111/coa.13097. [Epub ahead of print] No abstract available.

PMID:
29543405
41.

Mindfulness, cognitive behavioural and behaviour-based therapy for natural and treatment-induced menopausal symptoms: a systematic review and meta-analysis.

van Driel CM, Stuursma A, Schroevers MJ, Mourits MJ, de Bock GH.

BJOG. 2019 Feb;126(3):330-339. doi: 10.1111/1471-0528.15153. Epub 2018 Mar 15.

42.

The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?

Teixeira N, van der Hout A, Oosterwijk JC, Vos JR; HEBON, Devilee P, van Engelen K, Meijers-Heijboer H, van der Luijt RB, Kriege M, Mensenkamp AR, Rookus MA, van Roozendaal KE, Mourits MJE, de Bock GH.

Eur J Hum Genet. 2018 Jun;26(6):848-857. doi: 10.1038/s41431-018-0111-9. Epub 2018 Feb 26.

43.

A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening.

Koleva-Kolarova RG, Daszczuk AM, de Jonge C, Abu Hantash MK, Zhan ZZ, Postema EJ, Feenstra TL, Pijnappel RM, Greuter MJW, de Bock GH.

Maturitas. 2018 Mar;109:81-88. doi: 10.1016/j.maturitas.2017.12.009. Epub 2017 Dec 15. Erratum in: Maturitas. 2018 May 17;:.

PMID:
29452787
44.

Towards optimal personalized diet and vitamin supplementation in NET patients.

de Hosson LD, Stelwagen J, Bouma G, Sijtema B, Huitema S, van Faassen HJR, de Bock GH, de Groot DJA, Campmans-Kuijpers MJE, Kema IP, de Vries EGE, Walenkamp AME.

Endocr Relat Cancer. 2018 Mar;25(3):L23-L26. doi: 10.1530/ERC-17-0549. No abstract available.

PMID:
29431642
45.

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49).

Schrijnders D, Hendriks SH, Kleefstra N, Vissers PAJ, Johnson JA, de Bock GH, Bilo HJG, Landman GWD.

PLoS One. 2018 Jan 25;13(1):e0190870. doi: 10.1371/journal.pone.0190870. eCollection 2018.

46.

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.

Koopman T, Buikema HJ, Hollema H, de Bock GH, van der Vegt B.

Breast Cancer Res Treat. 2018 May;169(1):33-42. doi: 10.1007/s10549-018-4669-2. Epub 2018 Jan 18.

47.

Pretreatment identification of patients likely to have pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer.

van der Sluis FJ, van Westreenen HL, van Etten B, van Leeuwen BL, de Bock GH.

Int J Colorectal Dis. 2018 Feb;33(2):149-157. doi: 10.1007/s00384-017-2939-9. Epub 2017 Dec 15.

PMID:
29247263
48.

Reply to comment on: Incidence and predictors of postoperative delirium after cytoreduction surgery-hyperthermic intraperitoneal chemotherapy.

Plas M, Hemmer PHJ, Been LB, van Ginkel RJ, de Bock GH, van Leeuwen BL.

J Surg Oncol. 2018 Mar;117(4):808. doi: 10.1002/jso.24914. Epub 2017 Dec 11. No abstract available.

PMID:
29228456
49.

Diagnostic performance of semi-quantitative and quantitative stress CMR perfusion analysis: a meta-analysis.

van Dijk R, van Assen M, Vliegenthart R, de Bock GH, van der Harst P, Oudkerk M.

J Cardiovasc Magn Reson. 2017 Nov 27;19(1):92. doi: 10.1186/s12968-017-0393-z. Review. Erratum in: J Cardiovasc Magn Reson. 2018 Jan 4;20(1):3.

50.

Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.

Te Grootenhuis NC, Pouwer AW, de Bock GH, Hollema H, Bulten J, van der Zee AGJ, de Hullu JA, Oonk MHM.

Gynecol Oncol. 2018 Mar;148(3):622-631. doi: 10.1016/j.ygyno.2017.11.006. Epub 2017 Nov 12. Review.

PMID:
29137809

Supplemental Content

Loading ...
Support Center